Private non-profit organization; State Substance use treatment agency; State mental health department; State department of health; Federal, or any government funding for substance use treatment programs; IHS/Tribal/Urban (ITU) funds; Medicare; Medicaid; Private health insurance; Cash or self-payment; State-financed health insurance plan other than Medicaid; Sliding fee scale (fee is based on income and other factors); Adult women; Clients with co-occurring mental and substance use disorders; Comprehensive mental health assessment; Comprehensive substance use assessment; Interim services for clients; Outreach to persons in the community; Screening for tobacco use; Screening for substance use; Screening for mental disorders; Breathalyzer or blood alcohol testing; Drug and alcohol oral fluid testing; Drug or alcohol urine screening; HIV testing; Metabolic syndrome monitoring; Testing for Hepatitis B (HBV); Testing for Hepatitis C (HCV); Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge; Housing services; Assistance with obtaining social services; Recovery coach; Mentoring/peer support; Employment counseling or training; HIV or AIDS education, counseling, or support; Hepatitis education, counseling, or support; Health education services other than HIV/AIDS or hepatitis; Substance use disorder education; Smoking/vaping/tobacco cessation counseling; Individual counseling; Group counseling; Family counseling; Smoking not permitted; Children/adolescents; Female; Male; Sign language services for the deaf and hard of hearing; Vaping not permitted; Case management service; Mental health services; Social skills development; Transportation assistance; Suicide prevention services; Substance use treatment; Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children; Outpatient; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment; Buprenorphine used in Treatment; Naltrexone used in Treatment; In-network prescribing entity; No formal relationship with prescribing entity; Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere; This facility administers/prescribes medication for alcohol use disorder; In-network prescribing entity; No formal relationship with prescribing entity; Buprenorphine maintenance; Buprenorphine maintenance for predetermined time; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Accepts clients using MAT but prescribed elsewhere; Acamprosate (Campral®); Disulfiram; Buprenorphine with naloxone; Buprenorphine without naloxone; Naltrexone (oral); Naltrexone (extended-release, injectable); Clonidine; Medication for mental disorders; Non-nicotine smoking/tobacco cessation; Brief intervention; Cognitive behavioral therapy; Motivational interviewing; Matrix Model; Relapse prevention; Substance use disorder counseling; Telemedicine/telehealth therapy; Trauma-related counseling